Literature DB >> 20383144

Structures of influenza A proteins and insights into antiviral drug targets.

Kalyan Das1, James M Aramini, Li-Chung Ma, Robert M Krug, Eddy Arnold.   

Abstract

The world is currently undergoing a pandemic caused by an H1N1 influenza A virus, the so-called 'swine flu'. The H5N1 ('bird flu') influenza A viruses, now circulating in Asia, Africa and Europe, are extremely virulent in humans, although they have not so far acquired the ability to transfer efficiently from human to human. These health concerns have spurred considerable interest in understanding the molecular biology of influenza A viruses. Recent structural studies of influenza A virus proteins (or fragments) help enhance our understanding of the molecular mechanisms of the viral proteins and the effects of drug resistance to improve drug design. The structures of domains of the influenza RNA-dependent RNA polymerase and the nonstructural NS1A protein provide opportunities for targeting these proteins to inhibit viral replication.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383144      PMCID: PMC2957899          DOI: 10.1038/nsmb.1779

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  90 in total

1.  Oseltamivir resistance--disabling our influenza defenses.

Authors:  Anne Moscona
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

2.  Characterization of the 1918 influenza virus polymerase genes.

Authors:  Jeffery K Taubenberger; Ann H Reid; Raina M Lourens; Ruixue Wang; Guozhong Jin; Thomas G Fanning
Journal:  Nature       Date:  2005-10-06       Impact factor: 49.962

3.  Structural basis for sequence-nonspecific recognition of 5'-capped mRNA by a cap-modifying enzyme.

Authors:  A E Hodel; P D Gershon; F A Quiocho
Journal:  Mol Cell       Date:  1998-02       Impact factor: 17.970

4.  Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein.

Authors:  J Liu; P A Lynch; C Y Chien; G T Montelione; R M Krug; H M Berman
Journal:  Nat Struct Biol       Date:  1997-11

Review 5.  Crystallography and the design of anti-AIDS drugs: conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors.

Authors:  Kalyan Das; Paul J Lewi; Stephen H Hughes; Eddy Arnold
Journal:  Prog Biophys Mol Biol       Date:  2005-06       Impact factor: 3.667

6.  Influenza virus inhibits cleavage of the HSP70 pre-mRNAs at the polyadenylation site.

Authors:  K Shimizu; A Iguchi; R Gomyou; Y Ono
Journal:  Virology       Date:  1999-02-15       Impact factor: 3.616

7.  Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.

Authors:  Xiaojing He; Jie Zhou; Mark Bartlam; Rongguang Zhang; Jianyuan Ma; Zhiyong Lou; Xuemei Li; Jingjing Li; Andrzej Joachimiak; Zonghao Zeng; Ruowen Ge; Zihe Rao; Yingfang Liu
Journal:  Nature       Date:  2008-07-09       Impact factor: 49.962

8.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.

Authors:  M E Nemeroff; S M Barabino; Y Li; W Keller; R M Krug
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

9.  Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity.

Authors:  C U Kim; W Lew; M A Williams; H Liu; L Zhang; S Swaminathan; N Bischofberger; M S Chen; D B Mendel; C Y Tai; W G Laver; R C Stevens
Journal:  J Am Chem Soc       Date:  1997-01-29       Impact factor: 15.419

Review 10.  Assembly and budding of influenza virus.

Authors:  Debi P Nayak; Eric Ka-Wai Hui; Subrata Barman
Journal:  Virus Res       Date:  2004-12       Impact factor: 3.303

View more
  143 in total

1.  Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.

Authors:  John T-A Hsu; Jiann-Yih Yeh; Ta-Jen Lin; Mei-Ling Li; Ming-Sian Wu; Chung-Fan Hsieh; Yao Chieh Chou; Wen-Fang Tang; Kean Seng Lau; Hui-Chen Hung; Ming-Yu Fang; Shengkai Ko; Hsing-Pang Hsieh; Jim-Tong Horng
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Architecture and regulation of negative-strand viral enzymatic machinery.

Authors:  Philip J Kranzusch; Sean P J Whelan
Journal:  RNA Biol       Date:  2012-07-01       Impact factor: 4.652

3.  High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity.

Authors:  Ching-Yao Su; Ting-Jen R Cheng; Meng-I Lin; Shi-Yun Wang; Wen-I Huang; Shao-Ying Lin-Chu; Yu-Hou Chen; Chung-Yi Wu; Michael M C Lai; Wei-Chieh Cheng; Ying-Ta Wu; Ming-Daw Tsai; Yih-Shyun E Cheng; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

4.  Conjugation to polymeric chains of influenza drugs targeting M2 ion channels partially restores inhibition of drug-resistant mutants.

Authors:  Alyssa M Larson; Jianzhu Chen; Alexander M Klibanov
Journal:  J Pharm Sci       Date:  2013-07-06       Impact factor: 3.534

5.  Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study.

Authors:  Zhiwei Yang; Gang Yang; Lijun Zhou
Journal:  J Comput Aided Mol Des       Date:  2013-11-12       Impact factor: 3.686

6.  A small-RNA enhancer of viral polymerase activity.

Authors:  Jasmine T Perez; Ivan Zlatev; Shilpa Aggarwal; Sailakshmi Subramanian; Ravi Sachidanandam; Baek Kim; Muthiah Manoharan; Benjamin R tenOever
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

7.  T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro.

Authors:  Tatiana Baranovich; Sook-San Wong; Jianling Armstrong; Henju Marjuki; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

8.  Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain.

Authors:  Shuofeng Yuan; Naru Zhang; Kailash Singh; Huiping Shuai; Hin Chu; Jie Zhou; Billy K C Chow; Bo-Jian Zheng
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

9.  Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus.

Authors:  Nathalie Lejal; Bogdan Tarus; Edwige Bouguyon; Sylvie Chenavas; Nicolas Bertho; Bernard Delmas; Rob W H Ruigrok; Carmelo Di Primo; Anny Slama-Schwok
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

10.  3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease.

Authors:  Hye Yeon Sagong; Ajit Parhi; Joseph D Bauman; Disha Patel; R S K Vijayan; Kalyan Das; Eddy Arnold; Edmond J LaVoie
Journal:  ACS Med Chem Lett       Date:  2013-05-07       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.